Agency IQ

MARCH 29, 2024

What we expect European regulators to do in April 2024 In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations 40

Regulations Production Biosimilars Clinical Trials 40

Agency IQ

MAY 31, 2024

What we expect EU chemical regulators to do in June 2024 Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. Another consultation is closing this month on a draft implementing regulation that is amending the label format for fluorinated greenhouse gases (F-gases) under the new F-gas Regulation (EU) 2024/573.

Regulations 40

Regulations Production International Government 40

Agency IQ

MAY 31, 2024

This recurring feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Agency IQ

MARCH 1, 2024

What we expect European regulators to do in March 2024 In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations 40

Regulations Biosimilars Clinical Trials Production 40

Drug Discovery World

JUNE 12, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Laboratories 130

Laboratories Disease Regulations Drug Development 130

Agency IQ

MAY 3, 2024

This recurring feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Drug Discovery World

MAY 22, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Laboratories 147

Laboratories Disease Regulations Drug Development 147

Drug Discovery World

JUNE 5, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Laboratories 130

Laboratories Disease Regulations Drug Development 130

Drug Discovery World

MAY 29, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Drugs 130

Drugs Laboratories Disease Regulations 130

Agency IQ

OCTOBER 27, 2023

What we expect European regulators to do in November 2023 In this new recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations 40

Regulations Pharmaceuticals Production Packaging 40

Agency IQ

MAY 3, 2024

What we expect EU chemical regulators to do in May 2024 Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. On May 29-30, the agency will host ECHA IT Days , a two-day conference held in Helsinki, Finland dedicated to all things related to information technology and chemical regulations.

Regulations 40

Regulations Packaging Production International 40

Agency IQ

MARCH 1, 2024

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Agency IQ

FEBRUARY 2, 2024

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Agency IQ

DECEMBER 1, 2023

What we expect European regulators to do in December 2023 In this new recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

Agency IQ

JANUARY 4, 2024

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Agency IQ

MARCH 1, 2024

What we expect EU regulators to do in March 2024 Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. ECHA will hold two webinars, the first introducing the agency’s guidance on assessing biocide risks to bees, and the second providing insight into the OECD QSAR assessment framework in REACH’s dossier evaluation procedure.

Regulations 40

Regulations Production Packaging Science 40

FDA Law Blog: Biosimilars

MARCH 12, 2023

The COVID-19 pandemic emergency forced federal regulators to take extraordinary measures to ensure that patients were permitted continued access to important medicines. Please see detailed information in the attached flyer , including a link to register for our free webinar. Hyman, Phelps & McNamara, P.C.’s We hope you join us!

Regulations 98

Regulations Government FDA Drugs 98

Agency IQ

DECEMBER 1, 2023

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Drug Discovery World

JUNE 8, 2023

These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function.

Immune Response 130

Immune Response Laboratories Regulations Research 130

Agency IQ

OCTOBER 27, 2023

This ongoing feature compiles public information from across the EU to deliver an overview of all the chemical policy-related actions in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Agency IQ

JANUARY 12, 2024

device regulation timelines To kick off 2024, the British device regulator offered its medical device and IVD plans for this year and next, promising public action on the post-market surveillance regulation by mid-2024 and on the core regulations in late 2024 or early 2025. New roadmap sets out U.K.

Regulations 40

Regulations Compliance Government International 40

Drug Channels

AUGUST 21, 2020

As regular readers know, I believe the 340B Drug Pricing Program needs to evolve into a more transparent, properly regulated program. To help the industry learn more about 340B rebates, Kalderos is sponsoring a live video webinar: Evolving 340B: Moving from Discounts to Rebates. to 1:00 p.m. Registration is free and open to all.

Compliance 52

Compliance Regulations Drugs 52

Fierce BioTech

MAY 22, 2024

This webinar will delve into the benefits of Expanded Access Programs in Europe. In addition, EAPs can help serve as introductions to the dizzying array of regulations and guidelines in European countries. png Listing Introduction This webinar will delve into the benefits of Expanded Access Programs in Europe.

Marketing 52

Marketing Regulations Pharmaceuticals Treatment 52

Agency IQ

JANUARY 4, 2024

What we expect EU regulators to do in January 2024 Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. ECHA plays a central role in this reassignment of duties, and it would make sense for the basic regulation to be introduced at the same time as these other proposals.

Regulations 40

Regulations Packaging Production Government 40

Agency IQ

DECEMBER 1, 2023

What we expect EU regulators to do in December 2023 Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. Highlights of chemical regulatory activities Consultations open under the REACH and CLP regulations are coming to an end in December. Events happening next month include two ECHA meetings (i.e.,

Regulations 40

Regulations Production International Marketing 40

Agency IQ

FEBRUARY 2, 2024

What we expect EU regulators to do in February 2024 Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. BY SCOTT STEPHENS, MPA | JAN 26, 2024 10:22 PM CST Highlights of upcoming chemical regulatory activities Consultations under the REACH and CLP regulations are coming to an end in February.

Regulations 40

Regulations Production Government Marketing 40

Agency IQ

OCTOBER 27, 2023

What we expect EU regulators to do in November 2023 Welcome to AgencyIQ’s roundup of upcoming regulatory activities in the EU chemicals sector. Regulation on detergents and surfactants The expert working group on detergents is scheduled to hold a meeting on November 17.

Regulations 40

Regulations Production Packaging International 40

Agency IQ

MAY 31, 2024

What we expect the EPA to do in June 2024 The top line: In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. This is what OIRA is currently reviewing.

Regulations 40

Regulations Engineering International Research 40

Drug Discovery World

DECEMBER 2, 2022

Cell line development is labour intensive, time consuming and costly and is subject to stringent regulations to ensure patient safety. Dr Jonathan H Dempsey.

Regulations 130

Regulations Drugs 130

The Pharma Data

AUGUST 17, 2020

In this Pharma IQ webinar, Dassault Systèmes will analyze how to overcome the complex demands of digital manufacturing to improve production processes, control cost and assure quality. In addition, Dr. Holtz will dive into solutions as new regulations call for better data traceability. Sign up now to secure your free place.

Science 52

Science Regulations Production Marketing 52

Agency IQ

JUNE 28, 2024

What we expect the EPA to do in July 2024 In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. 801.26, OMB Control No. 801.26, OMB Control No. 801.26, OMB Control No.

Regulations 40

Regulations Engineering Government International 40

Agency IQ

SEPTEMBER 15, 2023

PFAS regulation in California (late 2023 edition) California consistently maintains its status as both one of the most important economies in the world as well as one of the most regulated states in the United States. In 2019, the state began to significantly ramp up its PFAS regulation and research.

Regulations 40

Regulations Packaging Production Organic Chemistry 40

Agency IQ

MAY 3, 2024

What we expect the EPA to do in May 2024 In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. TSCA new chemicals procedural regulations. TSCA risk management rules.

Regulations 40

Regulations Government Engineering International 40

Eye on FDA

JUNE 27, 2020

But in the United States, there are also an array of anti-discrimination laws; there are health privacy laws at both he federal and state levels; and there are regulations that guide what constitutes a safe workplace. You can register for the free Webinar here. It is not as uncomplicated as one might think. Share this:

Virus 52

Virus Vaccine Regulations Disease 52

Fierce BioTech

MAY 31, 2024

Listing Image QuartzListingLogo_250x190_sware.png Listing Introduction As AI capabilities push into GxP regulated business functions, how can Quality and IT teams partner to ensure they are properly controlled? Click here to login.

Production 52

Production Regulations Science 52

Fierce BioTech

APRIL 11, 2024

Don't miss out—register now for this essential webinar! Key takeaways: Plan ahead for storage needs, mitigate risk with a qualified partner, and how to find a provider who can meet your specific requirements. Click here to login. Listing Image Alcami_ListingLogo_250x190.png

Compliance 52

Compliance Pharmaceuticals Regulations FDA 52

Fierce BioTech

NOVEMBER 21, 2023

The Contract Transformation of the Biotech and BioPharma Industry swheeler Tue, 11/21/2023 - 18:43 Tue, 12/19/2023 - 12:00 Resource Type Webinar Angelina Bellanton Simon Jones Duration 60 minutes Either you want to implement a CLM, or you don’t know how to fix the processes of the one you have in place. Either is a tough place to be in.

Regulations 52

Regulations Pharmaceuticals International 52